Strategies for Primary Prevention of Coronary Heart Disease Based on Risk Stratification by the ACC/AHA Lipid Guidelines, ATP III Guidelines, Coronary Calcium Scoring, and C-Reactive Protein, and a Global Treat-All Strategy: A Comparative--Effectiveness Modeling Study

Open Access

Peer-reviewed

Research Article

Benjamin Z. Galper,

Affiliation Brigham and Women’s Hospital, Division of Cardiology, Boston, Massachusetts, United States of America
⨯
Y. Claire Wang,

Affiliation Columbia University Medical Center, Mailman School of Public Health, New York, New York, United States of America
⨯
Andrew J. Einstein

* E-mail: andrew.einstein@columbia.edu

Affiliations Columbia University Medical Center and New York-Presbyterian Hospital, Department of Medicine, New York, New York, United States of America, Columbia University Medical Center and New York-Presbyterian Hospital, Division of Cardiology, New York, New York, United States of America, Columbia University Medical Center and New York-Presbyterian Hospital, Department of Radiology, New York, New York, United States of America
⨯

Reader Comments (0)

Statins
Is the Subject Area "Statins" applicable to this article?

Thanks for your feedback.
Cardiovascular disease risk
Is the Subject Area "Cardiovascular disease risk" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Radiation therapy
Is the Subject Area "Radiation therapy" applicable to this article?

Thanks for your feedback.
Treatment guidelines
Is the Subject Area "Treatment guidelines" applicable to this article?

Thanks for your feedback.
Coronary heart disease
Is the Subject Area "Coronary heart disease" applicable to this article?

Thanks for your feedback.